Drug intelligence / Profile preview

Brain-Derived Neurotrophic Factor

Development stage
Unknown
Modality
Gene Therapies, Recombinant Proteins and Enzymes
Administration
Subcutaneous, Intracerebral
01

Overview

Brain-Derived Neurotrophic Factor (BDNF) is a protein belonging to the neurotrophin family of growth factors, crucial for the survival, growth, differentiation, and synaptic plasticity of neurons in both the central and peripheral nervous systems. It exerts its effects primarily by binding to its high-affinity receptor, tropomyosin receptor kinase B (TrkB), which activates various intracellular signaling cascades including IRS-1/2, PI-3K, Akt, and Ras-ERK-CREB pathways. These pathways regulate the expression of genes involved in neural plasticity, stress resistance, and cell survival. BDNF is vital for processes such as learning, memory, and higher-order thinking. Dysregulation of BDNF signaling has been implicated in a range of neurological and psychiatric conditions, including neurodegenerative diseases like Alzheimer's and Parkinson's, as well as psychiatric disorders such as depression and anxiety. The precursor form, proBDNF, can also bind to the low-affinity p75 neurotrophin receptor (p75NTR) and may have opposing effects, including promoting apoptosis. Therapeutic strategies involving BDNF, such as gene therapy (e.g., AAV2-BDNF), are under investigation for conditions like Alzheimer's disease.

Other names
AbrineurinNeurotrophic factor BDNF precursor form
02

Targets

NTRK2 (Tropomyosin-related kinase receptor type B)NGFR (p75NTR)

Beyond the preview

Go deeper on Brain-Derived Neurotrophic Factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brain-Derived Neurotrophic Factor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call